An Educational Platform about Current and Future Paradigms of Neuroimaging in the Management of Alzheimer's Disease.

Abstract

The first disease-modifying treatment (DMT) for Alzheimer's disease (AD) has been approved by the U.S. Food and Drug Administration (FDA) in 2021, with potentially more DMTs becoming available in the coming years. Neuroimaging was shown to support clinical decision making in the management of AD and will play a crucial role in determining patient eligibility and monitoring treatment efficacy and adverse events [1]. However, while neuroimaging takes center stage, image acquisition and analysis is rapidly becoming more complex. Training and education are critical for successful implementation of new imaging tools by (neuro)radiologists in daily clinical practice [2]. ALZimaging.com is a free e-learning platform about current and future neuroimaging paradigms in AD management, written by three medical experts. It offers six chapters containing a thorough literature review, retaining more than 250 peer-reviewed papers and guidelines about AD pathophysiology, neuroimaging protocols and tools for early and differential diagnosis, patient monitoring and safety reading. Additionally, all chapters are complemented by a quiz to test the users' knowledge. Four webinars with Accreditation Council for Continuing Medical Education (ACCME) are also included, presenting expert discussion panels and case studies. We present the qualitative assessment on the general acceptance and feedback about the e-learning platform, while the educational content was released gradually during the first year. Since the launch, over 2000 persons have visited the e-learning platform. The registered participants have read in average 71.5% of the content and the average quiz score is 3.5 out of 5 per chapter. For the Alzheimer's webinar series, more than 500 participants watched the live versions and completed the courses, resulting in the attainment of ACCME-accreditation. As feedback, the majority of (neuro)radiologists using the platform expressed their positivity and that knowledge gaps on neuroimaging were filled. The changing healthcare landscape of neuroimaging in dementia results in a strong interest in educational material. Platforms like ALZimaging.com providing curated and interactive educational resources leading to ACCME accreditation can play a crucial role to support the neuroradiology community in improving management of AD in care practice.